Recent early-stage clinical investigations of CAR T cells that autonomously secrete anti–IL-6 and IL-1RA resulted in moderate CRS with neurotoxicity during CRS (Figure 1Bmiddle) (42, 43). The gene discussed is IL6; the disease is congenital rubella syndrome.